Healthcare Services

Viral Vector Purification Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Viral Vector Purification Market By The End Of 2030?

The viral vector purification market has experienced rapid expansion in recent years. It is projected to increase from $1.75 billion in 2025 to $2.07 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 18.1%. The growth observed in prior periods can be attributed to an increase in viral vector manufacturing activities, the growing adoption of gene therapy research, the initial application of ultrafiltration and chromatography methods, a heightened focus on vector safety, and the accessibility of purification reagents and kits.

The viral vector purification market is anticipated to experience substantial expansion in the coming years, reaching a size of $3.98 billion by 2030, driven by a compound annual growth rate (CAGR) of 17.8%. This growth is primarily fueled by factors such as the escalating demand for clinical-grade viral vectors, increased investments in downstream bioprocessing technologies, the broadening of gene therapy pipelines, the expanding uptake of automated purification platforms, and stricter regulatory oversight concerning product purity. Key developments expected during this period involve a greater embrace of high-resolution chromatography methods, a heightened need for scalable purification solutions, the increased deployment of single-use purification systems, the growth of high-purity vector isolation procedures, and an intensified focus on optimizing process yields.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30429&type=smp

What Drivers Are Shaping The Future Growth Of The Viral Vector Purification Market?

The increasing need for gene therapies is projected to fuel the expansion of the viral vector purification market moving forward. Gene therapies represent medical interventions that involve the introduction, removal, or alteration of genetic material within a patient’s cells to manage or prevent diseases. The demand for these therapies is on the rise, driven by advancements in delivery systems that ensure safe, efficient, and targeted transportation of genetic material into cells. Viral vector purification is crucial as it enhances gene therapies by ensuring the production of high-quality, safe, and biologically active viral vectors. This process improves the effectiveness of therapies by eliminating impurities and optimizing vector performance, thereby supporting reliable and efficient treatment outcomes. For instance, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, indicated that the Food and Drug Administration (FDA) approved six gene therapy products in 2023, a rise from five approvals in 2022. Hence, the growing demand for gene therapies is a significant driver for the viral vector purification market.

Which Segment Classifications Shape The Viral Vector Purification Market?

The viral vector purification market covered in this report is segmented –

1) By Vector Type: Adenoviral Vectors, Lentiviral Vectors, Adeno-Associated Viral Vectors, Retroviral Vectors, Other Vector Types

2) By Product Type: Kits, Reagents, Instruments, Services

3) By Purification Technique: Chromatography, Ultrafiltration, Precipitation, Other Purification Techniques

4) By Application: Gene Therapy, Vaccinology, Research, Other Applications

5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End-Users

Subsegments:

1) By Adenoviral Vectors: First Generation, Second Generation, Third Generation

2) By Lentiviral Vectors: Integrating Lentiviral Vectors, Non Integrating Lentiviral Vectors

3) By Adeno Associated Viral Vectors: Recombinant Adeno Associated Viral Vectors, Self Complementary Adeno Associated Viral Vectors

4) By Retroviral Vectors: Gamma Retroviral Vectors, Alpha Retroviral Vectors, Beta Retroviral Vectors

How Are Trends Impacting The Viral Vector Purification Market?

Leading companies within the viral vector purification market are increasingly concentrating on swift, high-capacity analytical solutions, including macro mass photometry platforms, to boost process effectiveness, guarantee vector purity, and shorten development schedules. Macro mass photometry platforms are instruments that utilize light scattering to determine both the size and mass of viral particles, thereby facilitating accurate evaluation of empty versus full capsids and identifying degraded particles rapidly. An example is Refeyn Ltd., a UK-based biotechnology firm, which introduced KaritroMP, a macro mass photometry platform, in November 2023, capable of analyzing adenovirus and lentivirus vectors in under six minutes. This platform provides semi-automated processing for up to 13 samples, ensures strong reproducibility for quality control purposes, and allows the detection of minute variations in particle mass to aid purification optimization. Such advancements empower viral vector manufacturers with quicker and more precise evaluations of vector quality. Furthermore, it contributes to streamlining workflow efficiency, consequently decreasing the time and resources necessary for vector characterization and purification.

Which Companies Are Expanding Their Footprint In The Viral Vector Purification Market?

Major companies operating in the viral vector purification market are Merck KGaA, Thermo Fisher Scientific Inc., Lonza Group AG, FUJIFILM Diosynth Biotechnologies, Danaher Corporation, Sartorius AG, Agilent Technologies Inc., Eurofins Scientific SE, Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., AGC Biologics A/S, Takara Bio Inc., Miltenyi Biotec B.V. & Co. KG, Oxford Biomedica PLC, Revvity Inc., Applied Biological Materials Inc. (ABM), Creative Biolabs Inc., Repligen Corporation, Asahi Kasei Corporation, Promega Corporation, 3M Company

Read the full viral vector purification market report here:

https://www.thebusinessresearchcompany.com/report/global-viral-vector-purification-market-report

Which Geographic Regions Are Influencing Demand In The Viral Vector Purification Market?

North America was the largest region in the viral vector purification market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector purification market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Viral Vector Purification Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30429&type=smp

Browse Through More Reports Similar to the Global Viral Vector Purification Market 2026, By The Business Research Company

Viral Vector Manufacturing Global Market Report

https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Viral And Non Viral Vector Manufacturing Global Market Report

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Viral Inactivation Global Market Report

https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795